Increase in Coverage of Key Non-immunization Program Vaccines in China

Deputy Director of Innovation Lab for Vaccine Delivery Research Ph.D., University of New South Wales, Australia; Senior Consultant, Duke University, USA

Shu (Melinda) Chen's main research areas are health policies and systems, long-term care systems, infectious disease control, and healthy aging. She has published over twenty papers as first author and co-author in high-quality international journals (e.g. The Lancet Public Health, PLOS Medicine, BMJ Global Health). Melinda was the Associate Director of Research at Family Health International (FHI 360) Beijing Office, where she led the NIH-funded TB clinical trial research and capacity-building project. Prior to joining FHI 360, she was a Research Analyst and Coordinator of the Center for Global Health Research at Duke University in Kunshan, where she worked on health policy and systems research in the areas of major infectious diseases (e.g., tuberculosis and hepatitis) and chronic diseases (e.g., stroke and coronary heart disease). Melinda also has rich experience in working with international global health funders and partners, such as the Gates Foundation, World Bank, and NIH. She received her undergraduate degree from Peking University Health Science Center, and her master's degree from Duke University, US, and is expected to obtain her Ph.D. degree from the University of New South Wales, Australia in 2023.

Ph.D at Fudan University.

She has participated in many projects of the National Natural Science Foundation of China, the National Health and Health Commission, and local government health-related research projects,  publishing academic papers as first author and co-author in domestic and international academic journals (such as BMC Health Services Research, China Health Economics, China Health Policy Research, etc.). More than 10 articles.

Shenglan Tang, Mary D B T and James Semans International Professor of Medicine and Global Health at the Department of Population Health Science, Duke Medical School Professor, Duke Kunshan University.

Dr. Shenglan Tang is the Professor of Medicine and Global Health at Duke Global Health Institute. He is also Associate Director of DGHI for China Initiatives, and Executive Director of the Global Health Program at Duke Kunshan University in China, as well as Director of Research Hub for Asia-Pacific Observatory on Health Systems and Policies/WHO, which has research projects in Cambodia, Nepal, Vietnam, and other Asian countries. In November 2015, he was elected to serve as the president of the Chinese Consortium of Universities for Global Health (CCUGH)at his time of employment at Duke Kunshan University. Tang has more than 30 years of experience undertaking research on health systems reform, disease control, and maternal and child health in China and other countries, and has provided consultancy services on health systems strengthening to many international organizations and governments of developing countries. In 2012, Tang came to Duke from the UNICEF/UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR), based in Geneva, where he was Unit Leader for TB/HIV and Health Systems. Before his assignment at WHO, Tang was a faculty member at the Liverpool School of Tropical Medicine in the UK, and the School of Public Health of Fudan University (former Shanghai Medical University).

Professor, Ph.D. Supervisor. Director of Health Economics Teaching and Research Center, Department of Public Health, Fudan University; Deputy Director of the Health Technology Assessment (HTA) Lab affiliated with the Ministry of Health; Member of the Executive Committee of the Young Researchers and Secretary of the China Health Economics Association; Vice Chairman of the Pharmacoeconomics Committee of Shanghai Pharmaceutical Society; Vice Chairman of the Management Unit of the Shanghai Preventive Medicine Association; Member of the Teaching Steering Committee of Fudan University; Deputy Editor-in-Chief of World Clinical Drugs and the editorial board member of several journals.

His main research areas include health insurance and payment methods, health economics evaluation and Chinese medicine evaluation, health governance and information regulation, etc.